Hyperspectral imaging and FLAIR signal intensity: a step toward improved detection of nonenhancing glioma tissue
Neurosurgical Focus · 01.08.2025 · 59 (2) · E5
DOI: 10.3171/2025.5.focus25333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosurgical Focus, erschienen am 01.08.2025. Verfasst von Ferdinand Weber und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery, University Hospital Leipzig. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Hyperspectral Imaging, Magnetic Resonance Imaging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE Hyperspectral imaging (HSI) is an emerging new intraoperative, noninvasive, contrast agent–free, easy, and quick-to-use imaging modality. The present study aimed to correlate intraoperative HSI in glioma surgery with fluid attenuated inversion recovery (FLAIR) signal intensity. METHODS The present prospective study performed intraoperative in vivo HSI with the TIVITA Tissue system to measure spectral signatures ranging from 500 to 1000 nm. The following tissue parameters were measured: oxygen saturation, perfusion, and hemoglobin, water, and fat content. The signal intensity of noncontrast-enhancing FLAIR regions was measured using ImageJ. The datasets were analyzed for correlations between HSI parameters and FLAIR signal intensity. RESULTS Measurements were included from 15 patients. Histopathological analysis identified 10 cases of glioblastoma and 5 cases of astrocytoma, which were classified as WHO grade 2 (1 patient), WHO grade 3 (3 patients), and WHO grade 4 (1 patient). The area under the curve of the tissue water index (TWI) based on HSI for predicting increased FLAIR signal intensity was 0.70 (95% CI 0.40–0.99). TWI ≥ 0.416 had sensitivity and specificity of 75.0% and 85.7%, respectively. Six of 7 patients (85.7%) with TWI ≥ 0.416 had high FLAIR signal intensity, whereas 6 of 8 patients (75.0%) with TWI < 0.416 had low FLAIR signal intensity (p = 0.04). CONCLUSIONS The present investigation shows that the use of HSI to measure tissue water content correlates with the FLAIR signal intensity of nonenhancing glioma areas. Future studies evaluating the sensitivity and specificity of HSI to detect histopathologically confirmed nonenhancing glioma areas are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1Department of Neurosurgery, University Hospital Leipzig.
- 2Comprehensive Cancer Center Central Germany, Partner Site Leipzig; and.
- 3Innovation Center Computer Assisted Surgery (ICCAS), Faculty of Medicine, Leipzig University, Leipzig, Saxony, Germany.
Zitieren
APA
Weber, F., Pfahl, A., Köhler, H., Vychopen, M., Güresir, E., & Wach, J. (2025). Hyperspectral imaging and FLAIR signal intensity: a step toward improved detection of nonenhancing glioma tissue. Neurosurgical Focus, 59(2), E5. https://doi.org/10.3171/2025.5.focus25333
Vancouver
Weber F, Pfahl A, Köhler H, Vychopen M, Güresir E, Wach J. Hyperspectral imaging and FLAIR signal intensity: a step toward improved detection of nonenhancing glioma tissue. Neurosurgical Focus. 2025;59(2):E5. doi:10.3171/2025.5.focus25333
BibTeX
@article{Weber2025,
author = {Weber, Ferdinand and Pfahl, Annekatrin and Köhler, Hannes and Vychopen, Martin and Güresir, Erdem and Wach, Johannes},
title = {Hyperspectral imaging and FLAIR signal intensity: a step toward improved detection of nonenhancing glioma tissue},
journal = {Neurosurgical Focus},
year = {2025},
volume = {59},
number = {2},
pages = {E5},
doi = {10.3171/2025.5.focus25333}
}
EUVIMED